CA2858799A1 - Tricyclic boron compounds for antimicrobial therapy - Google Patents

Tricyclic boron compounds for antimicrobial therapy Download PDF

Info

Publication number
CA2858799A1
CA2858799A1 CA2858799A CA2858799A CA2858799A1 CA 2858799 A1 CA2858799 A1 CA 2858799A1 CA 2858799 A CA2858799 A CA 2858799A CA 2858799 A CA2858799 A CA 2858799A CA 2858799 A1 CA2858799 A1 CA 2858799A1
Authority
CA
Canada
Prior art keywords
compound
compounds
mixture
hci
stirred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2858799A
Other languages
English (en)
French (fr)
Inventor
Mikhail Fedorovich Gordeev
Jinqian Liu
Zhengyu Yuan
Xinghai Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICURX PHARMACEUTICALS Inc
Original Assignee
MICURX PHARMACEUTICALS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICURX PHARMACEUTICALS Inc filed Critical MICURX PHARMACEUTICALS Inc
Publication of CA2858799A1 publication Critical patent/CA2858799A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA2858799A 2011-12-22 2012-12-20 Tricyclic boron compounds for antimicrobial therapy Abandoned CA2858799A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579271P 2011-12-22 2011-12-22
US61/579,271 2011-12-22
PCT/IB2012/002880 WO2013093615A1 (en) 2011-12-22 2012-12-20 Tricyclic boron compounds for antimicrobial therapy

Publications (1)

Publication Number Publication Date
CA2858799A1 true CA2858799A1 (en) 2013-06-27

Family

ID=47664367

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2858799A Abandoned CA2858799A1 (en) 2011-12-22 2012-12-20 Tricyclic boron compounds for antimicrobial therapy

Country Status (7)

Country Link
US (1) US8530452B2 (enExample)
EP (1) EP2793901A1 (enExample)
JP (1) JP6031122B2 (enExample)
KR (1) KR20140114380A (enExample)
CN (1) CN104136032B (enExample)
CA (1) CA2858799A1 (enExample)
WO (1) WO2013093615A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
KR101666331B1 (ko) * 2013-01-30 2016-10-13 다우 아그로사이언시즈 엘엘씨 육류, 식물, 또는 식물 부분에 대한 휘발성 항미생물제로서의 벤족사보롤의 용도
KR101636431B1 (ko) * 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
EP4029870A1 (en) * 2013-08-09 2022-07-20 GlaxoSmithKline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
EA038093B1 (ru) * 2013-12-20 2021-07-05 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
WO2016001834A1 (en) 2014-07-01 2016-01-07 Daiichi Sankyo Company, Limited Tricyclic benzoxaboroles as antibacterial agents
CN104177226A (zh) * 2014-07-31 2014-12-03 河北国蓬化工有限公司 一种聚醚用催化剂的制备方法
MA41494B1 (fr) * 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
KR101925338B1 (ko) 2016-12-22 2018-12-05 엘에스산전 주식회사 전력기기 진단 장치
EP3850029A1 (en) 2019-08-09 2021-07-21 Safas Saf Plastik Sanayi Ve Ticaret Anonim Sirketi Boron-modified flexible polyurethane foam for hygiene and a method of production therefor
CA3239097A1 (en) 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
CN119233823A (zh) * 2022-06-23 2024-12-31 上海盟科药业股份有限公司 硼化合物治疗非结核分枝杆菌感染的方法和用途及用于治疗相同疾病的药物组合物
WO2025140370A1 (zh) * 2023-12-27 2025-07-03 上海盟科药业股份有限公司 硼化合物前药的盐型、晶型及其药物组合物和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US7465836B2 (en) 2003-06-16 2008-12-16 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
HRP20150710T1 (hr) * 2006-02-16 2015-08-14 Anacor Pharmaceuticals, Inc. Male molekule koje sadrže bor kao protu-upalni agensi
BRPI0711155A2 (pt) * 2006-05-02 2011-08-23 Anacor Pharmaceuticals Inc terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
US20070286822A1 (en) * 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
US20100256092A1 (en) * 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US20110259250A1 (en) * 2008-08-21 2011-10-27 Mcknight James T Systems And Methods For Converting Biomass In The Field To A Combustible Fluid For Direct Replacement Or Supplement To Liquid Fossil Fuels
CN102256494A (zh) 2008-12-17 2011-11-23 阿纳科制药公司 (s)-3-氨甲基-7-(3-羟基-丙氧基)-3h-苯并[c][1,2]氧杂硼杂环戊-1-醇的多晶型物
JP2013500974A (ja) 2009-07-28 2013-01-10 アナコール ファーマシューティカルズ,インコーポレイテッド 三置換ホウ素含有分子
EP2555625B1 (en) 2010-04-07 2018-11-14 GlaxoSmithKline LLC Process for preparing benzoxaboroles
PT3251678T (pt) 2010-09-07 2021-11-22 Anacor Pharmaceuticals Inc Derivados de benzoxaborol para tratamento de infeções bacterianas

Also Published As

Publication number Publication date
EP2793901A1 (en) 2014-10-29
CN104136032B (zh) 2018-11-13
CN104136032A (zh) 2014-11-05
US20130165411A1 (en) 2013-06-27
JP6031122B2 (ja) 2016-11-24
US8530452B2 (en) 2013-09-10
KR20140114380A (ko) 2014-09-26
WO2013093615A1 (en) 2013-06-27
JP2015502974A (ja) 2015-01-29

Similar Documents

Publication Publication Date Title
CA2858799A1 (en) Tricyclic boron compounds for antimicrobial therapy
CA2695616C (en) Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
KR20240040742A (ko) Kif18a 억제제로서의 화합물
JP7212142B2 (ja) Hpk1阻害剤およびその調製方法と応用
CA3190609A1 (en) Inhibitors of apol1 and methods of using same
JPH02502005A (ja) 新規なcc‐1065同族体
KR20230123522A (ko) 낭성 섬유증 막관통 전도도 조절제로서 사용하기 위한 1,3,4-옥사디아졸 고리를 함유하는 거대환
TWI834127B (zh) 噻吩類化合物及其應用
WO2010120112A2 (en) Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
US20120065170A1 (en) Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
JP7774326B2 (ja) 芳香族化合物、その医薬組成物及びその使用
CN117157279A (zh) 双环类化合物的制备方法及作为抗菌剂的应用
CA3116141C (en) Cycloalkane-1,3-diamine derivative
CN115244051B (zh) 苯并五元环类化合物
KR101872264B1 (ko) 신규한 유형의 시티딘 유도체 이량체 및 그의 용도
AU2023335416A1 (en) Egfr inhibitors and uses thereof
KR100729980B1 (ko) 항종양제로서비스-(n,n'-비스-(2-할로에틸)아미노)포스포라미데이트
TW202313578A (zh) 雙環類化合物的製備方法及作為抗菌劑的應用
CA3168355A1 (en) Macrocyclic indole derivatives as inhibitors of mcl-1
EP3717490A1 (en) Anti-bacterial heterocyclic compounds and their synthesis
CN116239600A (zh) 并环类化合物的制备方法及作为抗真菌剂的应用
CN116063243A (zh) 芳香化合物、其制备方法、中间体、药物组合物和应用
TW202233634A (zh) 囊腫纖維化跨膜傳導調節蛋白之調節劑
WO2025214344A1 (zh) 一种kras抑制剂及其在药学上的应用
WO2014195970A1 (en) Novel pyrrole compounds with silicon incorporation

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20171220

FZDE Discontinued

Effective date: 20200831

FZDE Discontinued

Effective date: 20200831